Oliver Mobasser is a Senior Associate in the Healthcare and Life Sciences group of the London office of Latham & Watkins. He advises clients in the healthcare and life sciences industry on a range of technology, intellectual property, and data-focused transactions and matters.
Mr Mobasser helps emerging and established multinational pharmaceutical, biotechnology, digital health, and medical technology companies as well as their investors navigate:
• Strategic licenses and collaborations
• Product acquisitions, divestments, and carve-outs
• Manufacturing, supply, distribution, and other commercial agreements
• Data protection, as well as data use, re-use, and exploitation
• Research and development and clinical trials
He has particular expertise and has contributed to a number of publications and conferences in complex data protection matters in the life sciences sector, including matters related to use of data in the context of clinical trials and other research, anonymisation, pseudonymisation, digital health and AI solutions.
Prior to joining Latham, Mr. Mobasser practised at a leading law firm in Dublin, Ireland, and completed a secondment as in-house counsel for Shire Pharmaceuticals. He brings a multifaceted, multijurisdictional perspective to his work for clients across Europe and North America. He regularly writes about topics at the intersection of healthcare, technology, and regulation.